A stratified precision medicine trial targeting α2A-adrenergic receptor agonism as a treatment for the cognitive biotype of depression

Related articles

1. A prospective biomarker-guided precision medicine trial of bupropion and sertraline for major depressive disorder: Sequential Multiple Assignment Randomized Trial in Depression (SMART-D)

   This article has 11 authors:

   1. Diego Pizzagalli
   2. Peter Zhukovsky
   3. Manuel Kuhn
   4. Lauren Borchers
   5. Boyu Ren
   6. Sarah Woronko
   7. Mohan Li
   8. Tracy Lam
   9. Ethan Zhang
   10. Brian Brennan
   11. Gordana Vitaliano

2. Genetic Evidence for a Novel Glutamatergic Augmentation in Treatment-Resistant OCD: CREB1 as a Key Driver of Impaired Plasticity

   This article has 1 author:

   1. Ngo Cheung

3. Optimizing Fingolimod Dosing in STZ-Induced Cognitive Impairment: Divergent Behavioral and Histopathological Responses Reveal a Narrow Neuroprotective Window

   This article has 14 authors:

   1. Alireza Khani-Robati
   2. Mohammad Banizaman
   3. Farima Jahromi
   4. Maryam Porsadeghfard
   5. Elahe Rafiei
   6. Sachchida Nand Rai
   7. Amirhossein Yousefi Nejad
   8. Somayeh Akbari
   9. Maryam Naseh
   10. Mahnaz Bayat
   11. Mohammad Saied Salehi
   12. Masoud Haghani
   13. Bijan Akbarpour
   14. Etrat Hooshmandi